SG11202012529VA - Means and methods for increased protein expression by use of transcription factors - Google Patents

Means and methods for increased protein expression by use of transcription factors

Info

Publication number
SG11202012529VA
SG11202012529VA SG11202012529VA SG11202012529VA SG11202012529VA SG 11202012529V A SG11202012529V A SG 11202012529VA SG 11202012529V A SG11202012529V A SG 11202012529VA SG 11202012529V A SG11202012529V A SG 11202012529VA SG 11202012529V A SG11202012529V A SG 11202012529VA
Authority
SG
Singapore
Prior art keywords
methods
protein expression
transcription factors
increased protein
increased
Prior art date
Application number
SG11202012529VA
Other languages
English (en)
Inventor
Richard Zahrl
Jonas Burgard
Kristin Baumann
Diethard Mattanovich
Brigitte Gasser
Original Assignee
Boehringer Ingelheim Rcv Gmbh
Validogen Gmbh
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Rcv Gmbh, Validogen Gmbh, Lonza Ag filed Critical Boehringer Ingelheim Rcv Gmbh
Publication of SG11202012529VA publication Critical patent/SG11202012529VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
SG11202012529VA 2018-06-27 2019-06-27 Means and methods for increased protein expression by use of transcription factors SG11202012529VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18180164 2018-06-27
PCT/EP2019/067133 WO2020002494A1 (en) 2018-06-27 2019-06-27 Means and methods for increased protein expression by use of transcription factors

Publications (1)

Publication Number Publication Date
SG11202012529VA true SG11202012529VA (en) 2021-01-28

Family

ID=62916411

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202012529VA SG11202012529VA (en) 2018-06-27 2019-06-27 Means and methods for increased protein expression by use of transcription factors

Country Status (9)

Country Link
US (1) US20210269811A1 (https=)
EP (1) EP3814491A1 (https=)
JP (2) JP7645076B2 (https=)
KR (1) KR20210032972A (https=)
CN (1) CN112955547B (https=)
AU (1) AU2019294515B2 (https=)
CA (1) CA3103988A1 (https=)
SG (1) SG11202012529VA (https=)
WO (1) WO2020002494A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018119142A1 (en) 2016-12-21 2018-06-28 Amgen Inc. Anti-tnf alpha antibody formulations
BR112022015325A2 (pt) * 2020-02-04 2022-09-27 Clara Foods Co Sistemas e métodos para alta produção de microganismos recombinantes e uso dos mesmos
ES3034258T3 (en) 2020-04-01 2025-08-14 Lonza Ag Helper factors for expressing proteins in yeast
CA3175683A1 (en) * 2020-04-29 2021-11-04 Xueyang FENG Compositions and methods for enhancing recombinant biosynthesis of cannabinoids
CN114657190B (zh) * 2022-04-06 2023-08-29 暨南大学 Msn2p作为负调控因子在提高宿主细胞中蛋白表达中的应用
CN114836461B (zh) * 2022-05-31 2024-03-29 华南理工大学 表达胶原蛋白酶的重组质粒、酵母菌株及其发酵培养基和发酵培养方法
CN115725632B (zh) * 2022-07-26 2023-12-22 深圳技术大学 一种Aomsn2过表达米曲霉工程菌及其构建方法与应用
EP4634389A1 (en) * 2022-12-16 2025-10-22 Boehringer Ingelheim RCV GmbH & Co KG Means and methods for increased protein expression by use of a combination of transport proteins and either chaperones or transcription factors
WO2025129656A1 (zh) * 2023-12-22 2025-06-26 中国科学院深圳先进技术研究院 一种模块化正交真核转录因子模型构建方法
CN117777275B (zh) * 2024-02-23 2024-05-31 北京国科星联科技有限公司 一种促进人乳铁蛋白在马克斯克鲁维酵母中分泌表达的方法
CN119220426B (zh) * 2024-12-05 2025-04-25 通化安睿特生物制药股份有限公司 一种重组毕赤酵母工程菌及其构建方法和应用
CN119799530B (zh) * 2024-12-31 2025-12-16 溧阳市优甜生物科技有限公司 重组酵母细胞及其在生产索马甜中的用途
CN120249088B (zh) * 2025-06-05 2025-09-09 上海欣瑞特生物医药技术有限公司 一种用于制备重组犬白蛋白的重组工程菌及其应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4601893A (en) 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DE4027453A1 (de) 1990-08-30 1992-03-05 Degussa Neue plasmide aus corynebacterium glutamicum und davon abgeleitete plasmidvektoren
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
DE4343591A1 (de) 1993-12-21 1995-06-22 Evotec Biosystems Gmbh Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
DE4440118C1 (de) 1994-11-11 1995-11-09 Forschungszentrum Juelich Gmbh Die Genexpression in coryneformen Bakterien regulierende DNA
JPH10229891A (ja) 1997-02-20 1998-09-02 Mitsubishi Rayon Co Ltd マロン酸誘導体の製造法
GB9704162D0 (en) 1997-02-28 1997-04-16 Medical Res Council Assay methods and means
US6949356B1 (en) 1999-10-20 2005-09-27 Microbia, Inc. Methods for improving secondary metabolite production in fungi
EP1373470B1 (en) * 2001-02-20 2013-04-24 Intrexon Corporation Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
JP2003000240A (ja) 2001-06-22 2003-01-07 National Research Inst Of Brewing 麹菌の固体培養発現遺伝子を制御する転写因子をコードするｄｎａ
WO2003012036A2 (en) 2001-07-27 2003-02-13 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Systems for in vivo site-directed mutagenesis using oligonucleotides
EP1680447A2 (en) * 2003-10-24 2006-07-19 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Orthogonal gene switches
US20050130306A1 (en) * 2003-12-10 2005-06-16 Richard Voellmy Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small molecule regulator
SI22056A (sl) * 2005-05-05 2006-12-31 Kemijski Institut Visoko-produkcijski rekombinantni sevi kvasovk s spremenjeno galaktozno regulacijo transkripcije
CA2644273A1 (en) * 2006-04-05 2008-03-27 Metanomics Gmbh Process for the production of a fine chemical
CN101679992A (zh) * 2007-04-20 2010-03-24 波利门科学生物免疫研究有限公司 酵母菌表达系统
WO2009058956A1 (en) * 2007-11-01 2009-05-07 Danisco Us, Inc. Signal sequences and co-expressed chaperones for improving protein production in a host cell
KR20100117465A (ko) * 2009-04-24 2010-11-03 삼성전자주식회사 호스트셀의 알코올 내성을 증대시키는 단리된 폴리뉴클레오티드, 이를 포함하는 벡터, 호스트셀 및 이를 이용한 알코올의 생산방법
EP2258854A1 (en) 2009-05-20 2010-12-08 FH Campus Wien Eukaryotic host cell comprising an expression enhancer
JP5585952B2 (ja) 2009-12-08 2014-09-10 独立行政法人酒類総合研究所 エタノールの製造方法
WO2011159153A2 (en) * 2010-06-15 2011-12-22 Universiteit Utrecht Holding B.V. Inducible promoter and its use
CN102643852B (zh) * 2011-02-28 2015-04-08 华东理工大学 光可控的基因表达系统
JP6295512B2 (ja) 2012-03-15 2018-03-20 株式会社豊田中央研究所 酵母における外来遺伝子の発現産物の生産方法、酵母における発現調節剤及びその利用
CN106661541B (zh) * 2014-04-17 2021-09-03 贝林格尔·英格海姆Rcv两合公司 被工程化为过表达辅助蛋白的重组宿主细胞
AU2015248807B2 (en) 2014-04-17 2021-07-22 Boehringer Ingelheim Rcv Gmbh & Co Kg Recombinant host cell for expressing proteins of interest
CN104031854B (zh) * 2014-06-20 2017-02-22 广西科学院 一株提高对乙醇耐受性的酿酒酵母基因工程菌株及其构建方法
KR102287810B1 (ko) * 2014-07-28 2021-08-09 삼성전자주식회사 Msn2의 활성이 증가되도록 유전적으로 조작된, 스트레스 내성을 갖는 효모 세포 및 그를 이용하여 락테이트를 생산하는 방법
EP3180440A4 (en) * 2014-08-11 2018-01-10 Butamax Advanced Biofuels LLC Yeast preparations and methods of making the same
EP3334751A1 (en) * 2015-08-13 2018-06-20 Glykos Finland Oy Regulatory protein deficient trichoderma cells and methods of use thereof
US12060394B2 (en) * 2016-04-28 2024-08-13 The Trustees Of Dartmouth College Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof
CN107267529B (zh) * 2017-07-20 2019-09-27 昆明理工大学 一种锌指蛋白转录因子基因RkMSN4及其应用

Also Published As

Publication number Publication date
CN112955547A (zh) 2021-06-11
KR20210032972A (ko) 2021-03-25
JP2021528985A (ja) 2021-10-28
EP3814491A1 (en) 2021-05-05
JP2025024050A (ja) 2025-02-19
WO2020002494A1 (en) 2020-01-02
US20210269811A1 (en) 2021-09-02
CN112955547B (zh) 2024-10-25
AU2019294515A1 (en) 2021-01-14
JP7645076B2 (ja) 2025-03-13
AU2019294515B2 (en) 2025-10-09
CA3103988A1 (en) 2020-01-02

Similar Documents

Publication Publication Date Title
SG11202012529VA (en) Means and methods for increased protein expression by use of transcription factors
IL277194A (en) Means and methods for glycoprofiling of protein
ZA202006092B (en) Imidazopiperazine inhibitors of transcription activating proteins
ZA202004919B (en) Anti-tigit antigen-binding proteins and methods of use thereof
IL276731A (en) Antibodies against CD73 and methods of using them
IL278821A (en) Anti-SIRPA antibodies and methods of using them
ZA202003695B (en) Anti-neuropilin antigen-binding proteins and methods of use thereof
SG11202010909RA (en) Anti-msr1 antibodies and methods of use thereof
ES3064150T3 (en) Anti-myostatin antibodies and methods of use
IL279648A (en) Anti-SIRP-in-cell 1 antibodies and methods of using them
EP3240799A4 (en) S-alkylated hepcidin peptides and methods of making and using thereof
ZA201906731B (en) Anti-sortilin antibodies and methods of use thereof
IL277212A (en) Anti-KLK5 antibodies and methods of use
IL280338A (en) Anti-SIGLEC-5 antibodies and methods of using them
IL283884A (en) Antibodies against il-36 and methods of using them
IL266720A (en) Proteins that bind against gitr antigens and methods of using them
IL279227A (en) Anti-SIGLEC-7 antibodies and methods of using them
GB201811641D0 (en) Methods for enabling movement of objects and associated apparatus
EP3271379A4 (en) Grp94 derived polypeptides for inhibiting pcsk9 and methods of use
SG11202112352TA (en) Expression of antigen-binding proteins in the nervous system
HK40047154A (en) Imidazopiperazine inhibitors of transcription activating proteins
AU2018904570A0 (en) Polypeptides and Methods for Improving Skin Conditions
GB201810835D0 (en) Methods of use
GB201801181D0 (en) Method of use
AU2014901643A0 (en) Methods and apparatus for characterisation of body tissue